Cargando…

Tumor suppression, dose-limiting toxicity and wellbeing with the fetal estrogen estetrol in patients with advanced breast cancer

PURPOSE: The aim of this study (the ABCE4 study) was to assess dose-limiting toxicity (DLT), safety, tolerability and preliminary efficacy of high doses of the fetal estrogen estetrol (E4) in postmenopausal patients with heavily pretreated, locally advanced and/or metastatic ER+/HER2−breast cancer,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schmidt, Marcus, Lenhard, Hans, Hoenig, Arnd, Zimmerman, Yvette, Krijgh, Jan, Jansen, Monique, Coelingh Bennink, Herjan J. T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Original Article – Clinical Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076125/ https://www.ncbi.nlm.nih.gov/pubmed/33242131 http://dx.doi.org/10.1007/s00432-020-03472-8

Ejemplares similares

Unique effects on hepatic function, lipid metabolism, bone and growth endocrine parameters of estetrol in combined oral contraceptives
por: Mawet, Marie, et al.
Publicado: (2015)

Inhibition of ovulation by administration of estetrol in combination with drospirenone or levonorgestrel: Results of a phase II dose-finding pilot study
por: Duijkers, Ingrid J.M., et al.
Publicado: (2015)

Estetrol Prevents Hot Flushes and Improves Quality of Life in Patients with Advanced Prostate Cancer Treated with Androgen Deprivation Therapy: The PCombi Study
por: Zimmerman, Yvette, et al.
Publicado: (2022)

Pro-Apoptotic Effects of Estetrol on Long-Term Estrogen-Deprived Breast Cancer Cells and at Low Doses on Hormone-Sensitive Cells
por: Yue, Wei, et al.
Publicado: (2019)

Estetrol Cotreatment of Androgen Deprivation Therapy in Infiltrating or Metastatic, Castration-sensitive Prostate Cancer: A Randomized, Double-blind, Phase II Trial (PCombi)
por: Coelingh Bennink, Herjan J.T., et al.
Publicado: (2021)

A multicenter, randomized, placebo-controlled study to select the minimum effective dose of estetrol in postmenopausal participants (E4Relief): part 2—vaginal cytology, genitourinary syndrome of menopause, and health-related quality of life
por: Gaspard, Ulysse, et al.
Publicado: (2023)

A multicenter, randomized study to select the minimum effective dose of estetrol (E4) in postmenopausal women (E4Relief): part 1. Vasomotor symptoms and overall safety
por: Gaspard, Ulysse, et al.
Publicado: (2020)

Treatment of Serious COVID-19 with Testosterone Suppression and High-dose Estrogen Therapy
por: Coelingh Bennink, Herjan J.T., et al.
Publicado: (2021)

Maintaining bone health by estrogen therapy in patients with advanced prostate cancer: a narrative review
por: Coelingh Bennink, Herjan J T, et al.
Publicado: (2022)

Testosterone suppression combined with high dose estrogen as potential treatment of SARS-CoV-2. A mini review
por: Coelingh Bennink, Herjan J.T., et al.
Publicado: (2022)

Target expression is a relevant factor in synthetic lethal screens
por: Schultz, Iman J., et al.
Publicado: (2022)

Reply to Bexultan Kazybay and Yingqiu Xie’s Letter to the Editor re: Herjan J.T. Coelingh Bennink, Jean-Michel Foidart, Frans M.J. Debruyne. Treatment of Serious COVID-19 with Testosterone Suppression and High-dose Estrogen Therapy. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.06.024
por: Coelingh Bennink, Herjan J.T., et al.
Publicado: (2021)

Estrogen receptors and estetrol-dependent neuroprotective actions: a pilot study
por: Tskitishvili, Ekaterine, et al.
Publicado: (2016)

Progesterone from ovulatory menstrual cycles is an important cause of breast cancer
por: Coelingh Bennink, Herjan J. T., et al.
Publicado: (2023)

Estetrol and Mammary Gland: Friends or Foes?
por: Gallez, Anne, et al.
Publicado: (2021)

Estetrol: A New Choice for Contraception
por: Fruzzetti, Franca, et al.
Publicado: (2021)

The benefits of estetrol addition to drospirenone for contraception
por: Foidart, Jean Michel, et al.
Publicado: (2023)

Pharmacology and Molecular Mechanisms of Clinically Relevant Estrogen Estetrol and Estrogen Mimic BMI-135 for the Treatment of Endocrine-Resistant Breast Cancer
por: Abderrahman, Balkees, et al.
Publicado: (2020)

Combined estrogenic and anti-estrogenic properties of estetrol on breast cancer may provide a safe therapeutic window for the treatment of menopausal symptoms
por: Gérard, Céline, et al.
Publicado: (2015)

Estetrol/Drospirenone: A Review in Oral Contraception
por: Lee, Arnold, et al.
Publicado: (2022)

Estetrol Increases Progesterone Genetic Response without Triggering Common Estrogenic Effects in Endometriotic Cell Lines and Primary Cultures
por: Patiño-García, Daniel, et al.
Publicado: (2023)

Correction: Estetrol/Drospirenone: A Review in Oral Contraception
por: Lee, Arnold, et al.
Publicado: (2022)

The uterine and vascular actions of estetrol delineate a distinctive profile of estrogen receptor α modulation, uncoupling nuclear and membrane activation
por: Abot, Anne, et al.
Publicado: (2014)

RF34 | PMON202 The Human Metabolic Profile of Estetrol
por: Gérard, Céline, et al.
Publicado: (2022)

An Oral Contraceptive Containing Estetrol 15 MG and Drospirenone 3 MG Has Limited Effects on Endocrine and Metabolic Parameters
por: Klipping, Christine, et al.
Publicado: (2021)

Estetrol Modulates Endothelial Nitric Oxide Synthesis in Human Endothelial Cells
por: Montt-Guevara, Maria Magdalena, et al.
Publicado: (2015)

Estetrol Combined to Progestogen for Menopause or Contraception Indication Is Neutral on Breast Cancer
por: Gallez, Anne, et al.
Publicado: (2021)

Low Thrombin Generation in Users of a Contraceptive Containing Estetrol and Drospirenone
por: Morimont, Laure, et al.
Publicado: (2022)

SUN-LB001 Estetrol (E4) Is a Unique Estrogen with Selective Actions in Tissues Which Are Distinctly Different from the Actions of SERMs
por: Foidart, Jean-Michel, et al.
Publicado: (2019)

Estetrol: From Preclinical to Clinical Pharmacology and Advances in the Understanding of the Molecular Mechanism of Action
por: Gérard, Céline, et al.
Publicado: (2023)

Effects of Estetrol on Migration and Invasion in T47-D Breast Cancer Cells through the Actin Cytoskeleton
por: Giretti, Maria Silvia, et al.
Publicado: (2014)

Use of estetrol with other steroids for attenuation of neonatal hypoxic-Ischemic brain injury: to combine or not to combine?
por: Tskitishvili, Ekaterine, et al.
Publicado: (2016)

Comparison of Estetrol Exposure between Women and Mice to Model Preclinical Experiments and Anticipate Human Treatment
por: Gallez, Anne, et al.
Publicado: (2023)

The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis
por: Zimmerman, Y., et al.
Publicado: (2014)

Fetal Wellbeing Monitoring: A Review Article
por: Jain, Suhani, et al.
Publicado: (2022)

Estetrol‐Drospirenone combination oral contraceptive: a clinical study of contraceptive efficacy, bleeding pattern and safety in Europe and Russia
por: Gemzell‐Danielsson, K, et al.
Publicado: (2021)

Amniotic fluid as a vital sign for fetal wellbeing
por: Dubil, Elizabeth A, et al.
Publicado: (2015)

Fetal nuchal translucency: is there an association with birthweight and neonatal wellbeing?
por: Kalem, Ziya, et al.
Publicado: (2019)

Estetrol Is Safe and Well Tolerated during Treatment of Hospitalized Men and Women with Moderate COVID-19 in a Randomized, Double-Blind Study
por: Foidart, Jean Michel, et al.
Publicado: (2023)

The toxic effects of subjective wellbeing and potential tonics
por: Atkinson, Sarah
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t54lqp05ccts4790hvdnvo88j0